Literature DB >> 29846032

A Structural View on Medicinal Chemistry Strategies against Drug Resistance.

Stefano Agnello1, Michael Brand1, Mathieu F Chellat1, Silvia Gazzola1, Rainer Riedl1.   

Abstract

The natural phenomenon of drug resistance is a widespread issue that hampers the performance of drugs in many major clinical indications. Antibacterial and antifungal drugs are affected, as well as compounds for the treatment of cancer, viral infections, or parasitic diseases. Despite the very diverse set of biological targets and organisms involved in the development of drug resistance, the underlying molecular mechanisms have been identified to understand the emergence of resistance and to overcome this detrimental process. Detailed structural information on the root causes for drug resistance is nowadays frequently available, so next-generation drugs can be designed that are anticipated to suffer less from resistance. This knowledge-based approach is essential for fighting the inevitable occurrence of drug resistance.
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  drug discovery; drug resistance; medicinal chemistry; structure-activity relationships; structure-based drug design

Year:  2019        PMID: 29846032     DOI: 10.1002/anie.201802416

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  6 in total

Review 1.  Application of Artificial Intelligence in Combating High Antimicrobial Resistance Rates.

Authors:  Ali A Rabaan; Saad Alhumaid; Abbas Al Mutair; Mohammed Garout; Yem Abulhamayel; Muhammad A Halwani; Jeehan H Alestad; Ali Al Bshabshe; Tarek Sulaiman; Meshal K AlFonaisan; Tariq Almusawi; Hawra Albayat; Mohammed Alsaeed; Mubarak Alfaresi; Sultan Alotaibi; Yousef N Alhashem; Mohamad-Hani Temsah; Urooj Ali; Naveed Ahmed
Journal:  Antibiotics (Basel)       Date:  2022-06-08

Review 2.  Systematic review on role of structure based drug design (SBDD) in the identification of anti-viral leads against SARS-Cov-2.

Authors:  Nilesh Gajanan Bajad; Swetha Rayala; Gopichand Gutti; Anjali Sharma; Meenakshi Singh; Ashok Kumar; Sushil Kumar Singh
Journal:  Curr Res Pharmacol Drug Discov       Date:  2021-05-14

3.  Synthesis and Biological Evaluation of RGD and isoDGR-Monomethyl Auristatin Conjugates Targeting Integrin αV β3.

Authors:  André Raposo Moreira Dias; Lizeth Bodero; Ana Martins; Daniela Arosio; Silvia Gazzola; Laura Belvisi; Luca Pignataro; Christian Steinkühler; Alberto Dal Corso; Cesare Gennari; Umberto Piarulli
Journal:  ChemMedChem       Date:  2019-03-22       Impact factor: 3.466

4.  Mechanistic Insights Into Co-Administration of Allosteric and Orthosteric Drugs to Overcome Drug-Resistance in T315I BCR-ABL1.

Authors:  Hao Zhang; Mingsheng Zhu; Mingzi Li; Duan Ni; Yuanhao Wang; Liping Deng; Kui Du; Shaoyong Lu; Hui Shi; Chen Cai
Journal:  Front Pharmacol       Date:  2022-03-18       Impact factor: 5.810

5.  Pyrimidine 2,4-Diones in the Design of New HIV RT Inhibitors.

Authors:  Roberto Romeo; Daniela Iannazzo; Lucia Veltri; Bartolo Gabriele; Beatrice Macchi; Caterina Frezza; Francesca Marino-Merlo; Salvatore V Giofrè
Journal:  Molecules       Date:  2019-05-02       Impact factor: 4.411

6.  Unraveling allosteric landscapes of allosterome with ASD.

Authors:  Xinyi Liu; Shaoyong Lu; Kun Song; Qiancheng Shen; Duan Ni; Qian Li; Xinheng He; Hao Zhang; Qi Wang; Yingyi Chen; Xinyi Li; Jing Wu; Chunquan Sheng; Guoqiang Chen; Yaqin Liu; Xuefeng Lu; Jian Zhang
Journal:  Nucleic Acids Res       Date:  2020-01-08       Impact factor: 16.971

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.